Table 2 Outcomes
|  | PRE (n = 83) | POST (n = 68) | P-value |
|---|---|---|---|
Primary Outcome | |||
Duration of empiric MRSA-targeted antibiotic therapy (hours, median [IQR]) | 72 [27–120] | 24 [12–72] | < 0.01 |
Secondary Outcomes | |||
MRSA coverage added back for MRSA (%) | 0.0 | 0.0 | --- |
AKI (%) | 15.7 | 6.1 | 0.07 |
LOS (days, median [IQR]) | 8.0 (5.0–13.0) | 9.0 (6.3–14.0) | 0.32 |
In-hospital mortality (%) | 2.4 | 2.9 | 1.00 |
9-month readmission due to DFI (%) | 18.1 | 31.3 | 0.06 |